GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
1 Year Est. Return
+28.28%
AUM
$1.61B
AUM Growth
+$447M
(+39%)
Holding
2,259
Top Buys
| 1 | +$39.8M | |
| 2 | +$32.6M | |
| 3 | +$28.3M | |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$23.1M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.9M |
Top Sells
| 1 | +$4.13M | |
| 2 | +$4.12M | |
| 3 | +$4.01M | |
| 4 |
Cheniere Energy
LNG
|
+$3.83M |
| 5 |
HOLX
Hologic
HOLX
|
+$3.1M |
Sector Composition
| 1 | Financials | 13.44% |
| 2 | Technology | 13.16% |
| 3 | Healthcare | 12.56% |
| 4 | Industrials | 12.41% |
| 5 | Consumer Discretionary | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Corbus Pharmaceuticals
CRBP
$140M
| – | – |
-11,056
|
|
||
2252
Carpenter Technology
CRS
$24B
| – | – |
-1,885
|
|
||
2253
CervoMed
CRVO
$27.2M
| – | – |
-26,431
|
|
||
2254
Corvus Pharmaceuticals
CRVS
$935M
| – | – |
-14,188
|
|
||
2255
Champions Oncology
CSBR
$78.5M
| – | – |
-20,978
|
|
||
2256
Capital Southwest
CSWC
$1.44B
| – | – |
-22,564
|
|
||
2257
CSX Corp
CSX
$87.3B
| – | – |
-26,738
|
|
||
2258
Cytosorbents Corp
CTSO
$28.8M
| – | – |
-148,374
|
|